232
Views
7
CrossRef citations to date
0
Altmetric
Research Articles

Microbial transformation of androstenedione by Cladosporium sphaerospermum and Ulocladium chartarum

ORCID Icon, ORCID Icon & ORCID Icon
Pages 7-14 | Received 23 Feb 2019, Accepted 03 Apr 2019, Published online: 02 May 2019
 

Abstract

In this work, incubations of androstenedione 1 with Cladosporium sphaerospermum MRC 70266 and Ulocladium chartarum MRC 72584 have been reported. C. sphaerospermum MRC 70266 mainly hydroxylated 1 at C-6β, accompanied by a hydroxylation at C-15α, a reduction at C-17, a 5α-reduction and oxidations at C-6 and C-16 following hydroxylations. U. chartarum MRC 72584 hydroxylated 1 at C-6β, C-7α, C-7β and C-14α, accompanied by an oxidation at C-6 following its hydroxylation, a reduction at C-17 and a 5α-reduction. 6β,17β-Dihydroxyandrost-4-en-3,16-dione 8, one of the metabolites from the incubation of 1 with C. sphaerospermum MRC 70266, was determined as a new compound.

Acknowledgements

We are grateful to Rasit Yilmaz, Yavuz Derin and Fatih Sonmez for running the 1H and 13C NMR spectra.

Disclosure statement

The authors report no declaration of interest. The authors alone are responsible for the content and writing of the article.

Additional information

Funding

This work was financially supported by the Sakarya Üniversitesi Scientific Research Foundation (Project no. 20182719), Turkey.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.